- Title
- A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects
- Creators
- Jonathan B Angel - Ottawa Hospital Research InstituteMark A Jacobson - Department of Medicine, University of California San Francisco and The Medical Service, San Francisco General Hospital, San Francisco, California, United StatesPaul R Skolnik - Tufts University School of Medicine, New England Medical Center, Boston, Massachusetts, United StatesMichael Giordano - Cornell Medical Center, New York, New York, United StatesLeland Shapiro - University of Colorado Health Sciences Center, Denver, Colorado, United StatesAlexandre Lebeaut - Schering Plough Research Institute, Kenilworth, New Jersey, United StatesWayne Greaves - Schering Plough Research Institute, Kenilworth, New Jersey, United StatesAmy C Fuchs - MCP Hahnemann University, Philadelphia, Pennsylvania, United States
- Publication Details
- AIDS (London), v 14(16), pp 2503-2508
- Publisher
- Lippincott Williams & Wilkins
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- MD (Doctor of Medicine) Program
- Web of Science ID
- WOS:000165320800012
- Scopus ID
- 2-s2.0-0033731101
- Other Identifier
- 991019169013104721
Journal article
A multicenter, randomized, double-blind, placebo-controlled trial of recombinant human interleukin-10 in HIV-infected subjects
AIDS (London), v 14(16), pp 2503-2508
2000
PMID: 11101061
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Metrics
Details
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Industry collaboration
- Domestic collaboration
- International collaboration
- Web of Science research areas
- Immunology
- Infectious Diseases
- Virology